American Journal of Perinatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 4, 2024
Objective
This
study
aimed
to
systematically
document
the
reported
omega-3
levels
in
commercially
available
prenatal
supplements
United
States
and
Canada,
compare
these
recommended
intakes
pregnancy.
Study
Design
Commercial
were
identified
using
Dietary
Supplement
Label
Database
(n
=
50)
Licensed
Natural
Health
Products
18).
Mean
proportion
of
products
meeting
recommendations
for
pregnant
women
tabulated.
Results
Average
368
±
33
mg
404
72
Canada.
Seventy
percent
61%
Canada
contained
amount
with
sufficient
intakes.
Sixteen
28%
dose
insufficient
Conclusion
These
results
illustrate
that
commercial
contain
a
wide
variety
fatty
acid
may
or
not
be
consistent
intake
levels.
Key
Points
Acta Obstetricia Et Gynecologica Scandinavica,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 20, 2024
Abstract
Introduction
Although
Omega‐3
is
thought
to
have
anticoagulative
properties,
the
potential
untoward
effects
of
during
pregnancy
not
been
investigated.
No
previous
studies
made
specifically
assess
its
effect
on
postpartum
hemorrhage
(PPH).
Our
aim
was
determine
if
an
association
exists
between
intake
and
profuse
PPH
or
massive
PPH.
Material
Methods
Data
all
deliveries
that
occurred
at
Karolinska
University
Hospital
years
2007–2011
(
n
=
41
139)
collected
from
medical
record
Obstetrix,
maternal
health
delivery
chart
system.
Women
with
reported
use
in
early
were
considered
exposed
other
as
unexposed.
Bivariate
adjusted
multivariate
analysis
performed
main
outcomes.
Results
associated
25%
increased
odds
(adjusted
ratio
(aOR)
1.25,
95%
confidence
interval
[CI]
(1.06–1.47))
a
more
than
doubled
(aOR
2.36,
CI
1.26–4.44).
In
addition,
there
minor
increase
amount
blood
loss.
few,
women
low‐dose
discontinued
terminated
36th
week
showed
no
significant
loss
measurements.
Conclusions
observational
findings
higher
two
times
who
using
pregnancy.
give
some
support
advocate
late
Revista da Associação Médica Brasileira,
Journal Year:
2024,
Volume and Issue:
70(11)
Published: Jan. 1, 2024
The
aim
of
this
study
was
to
assess
the
dietary
pattern
healthy
adult
and
adolescent
women,
pregnant
non-pregnant,
relate
profile
clinical
laboratory
characteristics.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 29, 2024
Preterm
birth
(delivery
prior
to
37
weeks)
appears
be
rising
globally,
increasing
the
risk
of
a
myriad
down-stream
disorders
which
affect
families,
their
offspring
and
society,
including
increased
morbidity,
mortality
economic
costs.
Strategies
for
prevention
preterm
have
therefore
become
priority
among
healthcare
providers.
One
proposed
strategy
is
consumption
Omega-3
long-chain
polyunsaturated
fatty
acids
(LC-PUFAs),
particularly
docosahexaenoic
acid
(DHA)
(from
food
or
supplements)
in
women
childbearing
age
during
pregnancy.
It
hypothesized
that
LC-PUFAs,
through
several
different
actions,
reduce
early
onset
labor
lengthen
gestation.
An
expert
group,
acting
on
behalf
relevant
organizations,
recently
published
guidance
based
compelling
trial
evidence
LC-PUFA
intake
protect
pregnancy
from
(PTB)
(ePTB).
Here,
we
consider
how
this
can
achieved
sustainable
manner.
We
present
data
suitable,
efficacious
alternatives
fish
as
source
so
while
aiming
families
society
against
PTB
ePTB
there
no
burden
other
species
our
vulnerable
planet.
Finally,
implemented
practice
discussed,
with
consideration
those
most
at
effective
ways
communicating
important
message.
American Journal of Perinatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 4, 2024
Objective
This
study
aimed
to
systematically
document
the
reported
omega-3
levels
in
commercially
available
prenatal
supplements
United
States
and
Canada,
compare
these
recommended
intakes
pregnancy.
Study
Design
Commercial
were
identified
using
Dietary
Supplement
Label
Database
(n
=
50)
Licensed
Natural
Health
Products
18).
Mean
proportion
of
products
meeting
recommendations
for
pregnant
women
tabulated.
Results
Average
368
±
33
mg
404
72
Canada.
Seventy
percent
61%
Canada
contained
amount
with
sufficient
intakes.
Sixteen
28%
dose
insufficient
Conclusion
These
results
illustrate
that
commercial
contain
a
wide
variety
fatty
acid
may
or
not
be
consistent
intake
levels.
Key
Points
